SuNMaP seeks to improve both diagnosis and treatment at health facilities, through capacity building and the provision of medical supplies. Efforts aim to ensure that both diagnosis and treatment are timely, affordable, acceptable and available at all times. This means helping to distribute and provide training for health workers on the use of artemisinin-based combination therapies (ACT) and rapid diagnostic tests.
SuNMap (Support to National Malaria Programme) was set up to support the Nigerian government tackle the burden of malaria, a disease that costs the country at least $1bn a year and causes thousands of deaths annually. Whilst malaria is both preventable and treatable, the public health system in Nigeria is overstretched. Health Partners International is a partner in the consortium managing SuNMaP, which is led by Malaria Consortium. The programme is funded by UK aid from the UK Government, and aims to provide much-needed support in efforts to reduce the burden of malaria in Nigeria.